Compare ACR & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACR | APYX |
|---|---|---|
| Founded | 2005 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.4M | 156.7M |
| IPO Year | N/A | 1987 |
| Metric | ACR | APYX |
|---|---|---|
| Price | $18.65 | $3.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $24.50 | $7.00 |
| AVG Volume (30 Days) | 27.8K | ★ 150.9K |
| Earning Date | 03-04-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.65 | N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | ★ $88,952,000.00 | $47,902,000.00 |
| Revenue This Year | $3.67 | $9.36 |
| Revenue Next Year | $1.87 | $6.70 |
| P/E Ratio | $19.49 | ★ N/A |
| Revenue Growth | ★ 14.87 | N/A |
| 52 Week Low | $16.51 | $0.76 |
| 52 Week High | $24.61 | $4.50 |
| Indicator | ACR | APYX |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 49.59 |
| Support Level | $17.91 | $3.70 |
| Resistance Level | $18.97 | $3.96 |
| Average True Range (ATR) | 0.59 | 0.29 |
| MACD | 0.04 | -0.04 |
| Stochastic Oscillator | 52.88 | 34.78 |
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.